Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 1
2013 1
2014 4
2015 1
2016 1
2017 3
2018 1
2019 2
2020 6
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
Rosmarin D, Passeron T, Pandya AG, Grimes P, Harris JE, Desai SR, Lebwohl M, Ruer-Mulard M, Seneschal J, Wolkerstorfer A, Kornacki D, Sun K, Butler K, Ezzedine K; TRuE-V Study Group. Rosmarin D, et al. Among authors: ruer mulard m. N Engl J Med. 2022 Oct 20;387(16):1445-1455. doi: 10.1056/NEJMoa2118828. N Engl J Med. 2022. PMID: 36260792
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
Silverberg JI, Guttman-Yassky E, Thaçi D, Irvine AD, Stein Gold L, Blauvelt A, Simpson EL, Chu CY, Liu Z, Gontijo Lima R, Pillai SG, Seneschal J; ADvocate1 and ADvocate2 Investigators. Silverberg JI, et al. N Engl J Med. 2023 Mar 23;388(12):1080-1091. doi: 10.1056/NEJMoa2206714. Epub 2023 Mar 15. N Engl J Med. 2023. PMID: 36920778 Clinical Trial.
Secukinumab in plaque psoriasis--results of two phase 3 trials.
Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, Rivas E, Tsai TF, Wasel N, Tyring S, Salko T, Hampele I, Notter M, Karpov A, Helou S, Papavassilis C; ERASURE Study Group; FIXTURE Study Group. Langley RG, et al. N Engl J Med. 2014 Jul 24;371(4):326-38. doi: 10.1056/NEJMoa1314258. Epub 2014 Jul 9. N Engl J Med. 2014. PMID: 25007392 Free article. Clinical Trial.
[Off-label drugs in childhood psoriasis].
Mahé E, Corgibet F, Maccari F, Hadj-Rabia S, Phan C, Ruer-Mulard M, Boralévi F, Barbarot S, Bursztejn AC, Lahfa M, Severino-Freire M, Aubin F, Barthélémy H, Amy de la Bretêque M, Beauchet A; groupe de recherche de la Société française de dermatologie pédiatrique; le groupe de recherche sur le psoriasis de la Société française de dermatologie; la Fédération française de formation continue et d’évaluation en dermatologie-vénéréologie; et le GEM Resopso. Mahé E, et al. Among authors: ruer mulard m. Ann Dermatol Venereol. 2020 Jun-Jul;147(6-7):429-438. doi: 10.1016/j.annder.2020.01.021. Epub 2020 Apr 13. Ann Dermatol Venereol. 2020. PMID: 32299624 French.
Tattoo complications in treated and non-treated psoriatic patients.
Grodner C, Beauchet A, Fougerousse AC, Quiles-Tsimaratos N, Perrot JL, Barthelemy H, Parier J, Maccari F, Beneton N, Bouilly-Auvray D, Ruer-Mulard M, Boulard C, Jacobzone C, Thomas-Beaulieu D, Pourchot D, Méry-Bossard L, Chaby G, Girard C, Duval-Modeste AB, Vermersch-Langlin A, Delaunay J, Marc S, Kemula M, Steff M, Bilan P, Liégeon AL, Aubert H, Solyga B, Kluger N, Mahé E; GEM Resopso. Grodner C, et al. Among authors: ruer mulard m. J Eur Acad Dermatol Venereol. 2020 Apr;34(4):888-896. doi: 10.1111/jdv.15975. Epub 2019 Oct 24. J Eur Acad Dermatol Venereol. 2020. PMID: 31568596
Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis.
Phan C, Beneton N, Delaunay J, Reguiai Z, Boulard C, Fougerousse AC, Cinotti E, Romanelli M, Mery-Bossard L, Thomas-Beaulieu D, Parier J, Maccari F, Perrot JL, Ruer-Mulard M, Bastien M, Begon E, Samimi M, Jacobzone C, Quiles-Tsimaratos N, Descamps V, Steff M, Bilan P, Vermersch-Langlin A, Kemula M, Amazan E, Kupfer-Bessaguet I, Cottencin AC, Prignano F, Livideanu B, Gottlieb J, Beauchet A, Mahé E; the Groupe d’Etudes Multicentriques (GEM) RESOPSO. Phan C, et al. Among authors: ruer mulard m. Acta Derm Venereol. 2020 Nov 4;100(18):adv00316. doi: 10.2340/00015555-3678. Acta Derm Venereol. 2020. PMID: 33111960 Free PMC article.
Socioeconomic Inequalities and Severity of Plaque Psoriasis at a First Consultation in Dermatology Centers.
Mahé E, Beauchet A, Reguiai Z, Maccari F, Ruer-Mulard M, Chaby G, Le Guyadec T, Estève E, Goujon-Henry C, Parier J, Barthelemy H, Bégon E, Steiner HG, Bénéton N, Boyé T, Mery-Bossard L, Schmutz JL, Bravard P; Michèle-Léa Sigal and the GEM RESOPSO. Mahé E, et al. Among authors: ruer mulard m. Acta Derm Venereol. 2017 May 8;97(5):632-638. doi: 10.2340/00015555-2625. Acta Derm Venereol. 2017. PMID: 28127620 Free article.
Real-World Effectiveness and Safety of Apremilast in Older Patients with Psoriasis.
Phan C, Beneton N, Delaunay J, Reguiai Z, Boulard C, Fougerousse AC, Cinotti E, Romanelli M, Mery-Bossard L, Thomas-Beaulieu D, Parier J, Maccari F, Chaby G, Bastien M, Begon E, Samimi M, Prignano F, Beauchet A, Mahé E; GEM Resopso. Phan C, et al. Drugs Aging. 2020 Sep;37(9):657-663. doi: 10.1007/s40266-020-00781-y. Drugs Aging. 2020. PMID: 32696432
Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate-to-severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI-PSO study.
Richard MA, Lacour JP, Konstantinou MP, Ruer-Mulard M, Joly P, Aractingi S, Auquier P, Pelvet B, Augustin ML, Mahé E, Chalmers RJG. Richard MA, et al. Among authors: ruer mulard m. J Eur Acad Dermatol Venereol. 2021 Mar;35(3):677-684. doi: 10.1111/jdv.16893. Epub 2020 Oct 2. J Eur Acad Dermatol Venereol. 2021. PMID: 32815591 Free PMC article.
Improvement of patient outcomes following therapeutic optimization of chronic urticaria: two-year data from France as part of the international real-life AWARE study.
Giordano-Labadie F, Becherel PA, Pralong P, Outtas O, Ruer-Mulard M, Berard F, Greco M, Lacour JP, Debons-Peyroutet M, Pelvet B, Lamirand A, Guillet G. Giordano-Labadie F, et al. Among authors: ruer mulard m. Eur J Dermatol. 2021 Apr 1;31(2):217-224. doi: 10.1684/ejd.2021.4023. Eur J Dermatol. 2021. PMID: 34001470
21 results